Type 2 diabetic women are not small type 2 diabetic men: Sex-and-gender differences in antidiabetic drugs
- PMID: 34325380
- DOI: 10.1016/j.coph.2021.06.007
Type 2 diabetic women are not small type 2 diabetic men: Sex-and-gender differences in antidiabetic drugs
Abstract
Many pieces of evidence have accumulated over time suggesting sex-and-gender differences in type 2 diabetes, the most relevant being the greater excess risk of cardiovascular diseases in women with diabetes than in men. Drugs available for the treatment of diabetes have, meanwhile, increased in number and effectiveness over the last 20 years. Nonetheless, overall metabolic control of diabetes continues to be suboptimal, with a clear further disadvantage for women. Moreover, old and new glucose-lowering drugs present some sex-and-gender differences, although women continue to be underrepresented in all cardiovascular outcome trials testing their efficacy and protective effects. We conclude that pharmacology should wear gender glasses starting from preclinical research to overcome all these gender gaps.
Copyright © 2021 Elsevier Ltd. All rights reserved.
Conflict of interest statement
Conflict of interest statement Nothing declared.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical